Top Abstract Purchase Related
Home
>
Node
>
Subnode

Efficiency of mexidol in patients with endocrine polyneuropathy

Kuznetsova, E.B.; Sholomov, I.I.; Gerasimov, S.V.; Salina, E.A.

Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(4): 97-99

2014

ISSN/ISBN: 1997-7298
PMID: 24874328
Document Number: 673734
To evaluate the efficacy of mexidol and necessity of using it in patients with endocrine polyneuropathies caused by primary hypothyroidism (PPHT). MATERIALS AND METHODS; We have examined 51 patients with confirmed diagnosis of PPHT and assessed their neurological status and indicators of metabolic homeostasis before and after treatment. Electroneuromyography (ENMG) was performed to assess the status of the peripheral nervous system. The results indicate the presence of endocrine disorders of obligate metabolic homeostasis in patients with polyneuropathies. Antioxidants, in particular, mexidol, in a complex with other drugs can be used in the treatment of these disorders. Worsening of ENMG-parameters, demonstrating a trend towards the normalization in response to treatment antioxidants, are characteristics of this pathology. The efficacy of mexidol in patients with PPHT has been confirmed.

Document emailed within 1 workday
Secure & encrypted payments

Natriashvili, G.D.; Kapanadze, N.B.; Natriashvili, S.G. 2005: Efficiency of mexidol during perinatal encephalopathy in early age children Georgian Medical News 123: 35-39
Lièvre, J.A. 1977: Plasma cell dyscrasia with polyneuropathy endocrine disorders and nodular osteocondensation resembling osteopoikilosis Revue du Rhumatisme et des Maladies Osteo-Articulaires 44(4): 281-284
Sariev, A.K.; Zherdev, V.P.; Litvin, A.A.; Kolyvanov, G.B.; Neznamov, G.G.; Petrova, T.N.; Davydova, I.A. 1999: The kinetics of the urinary excretion of mexidol and its glucuronate conjugate in patients Eksperimental'naia i Klinicheskaia Farmakologiia 62(5): 42-46
Shatrova, V.P.; Meskhi, K.T. 2008: Mexidol in the post-surgery rehabilitation of patients with degenerative-dystrophic diseases of the spine Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(12): 68-70
Kursakov, E.S.; Remizevich, R.S. 2013: The effect of mexidol in the combination with antidepressants on sleep disturbance in young patients with panic disorder Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(2): 33-38
Belaia, O.L.; Baĭder, L.M.; Kuropteva, Z.V.; Fomina, I.G. 2005: Effects of mexidol on the antioxidative status of patients suffering from coronary heart disease with dislipidemia Klinicheskaia Meditsina 83(10): 57-60
Niewiadomska, M.; Piłkowska, E.; Wochnik-Dyjas, D. 1986: Comparison of electrophysiologic changes in persons with alcoholic polyneuropathy and polyneuropathy caused by carbon disulfide Neurologia i Neurochirurgia Polska 20(5): 453-460
Lehy, T.; Cadiot, G.; Mignon, M.; Ruszniewski, P.; Bonfils, S. 1992: Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome Gut 33(9): 1275-1279
Sariev, A.K.; Davydova, I.A.; Neznamov, G.G.; Zherdev, V.P.; Teleshova, E.S. 2001: Relation between mexidol glucuronide conjugation and characteristics of its therapeutic effect in patients with organic lesions in the central nervous system Eksperimental'naia i Klinicheskaia Farmakologiia 64(3): 17-21
Volchegorskiĭ, I.A.; Alekseev, M.N.; Volchegorskaia, M.I.; Rassokhina, L.M. 2008: Effect of alpha-lipoic acid and mexidol on neuro- and the affective status in patients at early stages of diabetic foot syndrome Klinicheskaia Meditsina 86(10): 52-59
Volchegorskiĭ, I.A.; Moskvicheva, M.G.; Chashchina, E.N. 2005: Effects of emoxipine, reamberine and mexidol on neuropathic symptoms and a systolic function of the left ventricular myocardium in patients with diabetes mellitus and diabetic foot syndrome Terapevticheskii Arkhiv 77(10): 10-15
Ohnishi, A.; Itoyama, Y.; Kuroiwa, Y. 1984: Histopathological findings of the sural nerve in chronic polyneuropathy associated with skin hyperpigmentation and dysglobulinemia--comparison with those in chronic polyneuropathy associated with IgM kappa paraproteinemia Rinsho Shinkeigaku 24(2): 189-194
Salama, J.; Hauw, J.J.; Dubas, F.; Giroux, C.; Frison, A.; Delaporte, P. 1984: Adie's syndrome and polyneuropathy: apropos of a new case and a case of pupillotonia, polyneuropathy and generalized amyloidosis sparing the nerve Annales de Medecine Interne 135(1): 39-42
Niewiadomska, M.; Wochnik-Dyjas, D. 1981: Electrophysiological diagnosis of polyneuropathy of demyelination type. Part I. Electrophysiological features of primarily demyelinative polyneuropathy - results of examination in the acute and residual period of the Guillain-Barré syndrome Electromyography and Clinical Neurophysiology 21(4): 387-401
Knezević, A.; Kovac, I. 1990: Psychological changes in diabetic patients with polyneuropathy Medicinski Pregled 43(3-4): 140-142
Frederiksen, P.K. 1974: Polyneuropathy. Follow-up of patients with polyneuropathia cryptogenica Ugeskrift for Laeger 137(1): 26-28
Kapustina, L.A.; Nesterova, O.S.; Boĭko, A.N.; Stulin, I.D.; Antsiferov, M.B. 2009: Quality of life of patients with diabetic polyneuropathy Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(3): 47-52
Coyle, P.K.; Schutzer, S.E.; Sterman, A.B.; Peress, N.; Miller, F. 1985: Humoral abnormalities in three patients with idiopathic chronic polyneuropathy New York State Journal of Medicine 85(6): 248-250
Villa, A.M.; Molina, H.; Sanz, O.P.; Sica, R.E. 1999: Chronic inflammatory demyelinating polyneuropathy. Findings in 30 patients Medicina 59(6): 721-726
Markov, D.V.; Rusenko, N.I.; Inozemtseva, E.S. 2007: Electrostatic field in the treatment of patients with diabetic polyneuropathy of the lower limbs Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 4: 41-43